NEW YORK, Jan. 9 (GenomeWeb News) - Keygene purchased 454's Genome Sequencer 20 system from Roche Diagnostics, the companies announced today.
Keygene is Roche's first European customer for the sequencing system.
The Genome Sequencer 20 System takes a nanotechnology based approach to sequencing and was developed by 454 Life Sciences. The system sequences over 20 million bases within a four and a half hour run, Roche said.
Roche, 454 Life Sciences, and Kegene will use the system with Keygene's AFLP and SNPWave technologies to develop applications in plant genetics.